Consistent Benefit of Control-IQ+ Automated Insulin Delivery Across a Range of Characteristics of Adults with Type 2 Diabetes
Authors' conclusion
The glycemic benefit of AID was observed across a wide range of participant characteristics. Furthermore, there were no identifiable characteristics that were associated with unsuccessful use of AID or a lack of beneficial glycemic response with AID.
Study context
- Population
- Adults with insulin-treated T2D
- Participants
- 319 adults
- Comparison
- Automated insulin delivery (AID) vs control
Primary result
As reported in the abstract
Glycemic improvement with AID by participant characteristics · 13 weeks
- Glycemic improvement with AID across age, sex, race/ethnicity, education level and baseline HbA1c; not dependent on prior pump experience or carbohydrate counting knowledge
Further findings
%
| Outcome | AID | Control |
|---|---|---|
| Change in HbA1c, baseline HbA1c ≥9.0% subgroup | −2.3 (SD 1.2) | −1.0 (SD 1.1) |
- Dropped from study or discontinued AID before 13 weeks
- 8.8% · 19 events
Dropped from study or discontinued AID before 13 weeks
- No clear pattern of characteristics differentiated those who discontinued AID from those with AID active ≥90% of the time
Original publication
Consistent Benefit of Control-IQ+ Automated Insulin Delivery Across a Range of Characteristics of Adults with Type 2 Diabetes. Diabetes Technol Ther. Published 23 January 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →